Cargando…
Use of Pharmacogenetic Drugs by the Dutch Population
INTRODUCTION: The Dutch Pharmacogenetics Working Group (DPWG) indicated a list of actionable genotypes that affect patients’ response to more 50 drugs; these drugs which show variable effects based on patients’ genetic traits were named as pharmacogenetics (PGX) drugs. Preemptive genetic testing bef...
Autores principales: | Alshabeeb, Mohammad A., Deneer, Vera H. M., Khan, Amjad, Asselbergs, Folkert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614185/ https://www.ncbi.nlm.nih.gov/pubmed/31312209 http://dx.doi.org/10.3389/fgene.2019.00567 |
Ejemplares similares
-
Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients
por: den Uil, Manon G., et al.
Publicado: (2023) -
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines
por: Lunenburg, Carin A. T. C., et al.
Publicado: (2019) -
HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population
por: Nakkam, Nontaya, et al.
Publicado: (2018) -
Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard
por: Alshabeeb, Mohammad A., et al.
Publicado: (2022) -
Enrollment of Diverse Populations in the INGENIOUS Pharmacogenetics Clinical Trial
por: Shah-Williams, Ebony, et al.
Publicado: (2020)